MARTIN SAMUEL BATES

PrivateCIK: 1709024
Location

HAMPTON, NJ

MARTIN SAMUEL BATES (SVP and CFO) sold 37.9% of their position (17.17K shares) of CELLDEX THERAPEUTICS, INC. on the open market

Open‑market sale worth $608.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderMARTIN SAMUEL BATESCIK 1709024
Officer· SVP and CFO
Since Jun 2019
-17.17K
Net shares
Net seller
$608.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
20.17K acquired · 37.34K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+3.20K

Price / share

$9.02

Trade value

$28.86K

% of position

12.7%
6/14/2024
25.13K28.33K

Common Stock

Direct
M · Option Exercise

Shares

+16.97K

Price / share

$10.38

Trade value

$176.13K

% of position

59.9%
6/14/2024
28.33K45.30K

Common Stock

Direct
S · Sale

Shares

17.17K

Price / share

$35.42

Trade value

$608.31K

% of position

37.9%
6/14/2024
45.30K28.13K
Total

Net shares

+3K

Net value

-$403.33K

Derivative Transactions2

Incentive Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

3.20K shares

Shares

3.20K

Strike price

9.0165

Held after

0.00

Exercisable

6/14/2024

Incentive Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

16.97K shares

Shares

16.97K

Strike price

10.38

Held after

63.63K

Exercisable

6/14/2024
MARTIN SAMUEL BATES — Insider Transaction (Form 4) Filed Jun 18, 2024 | Finecho